v3.26.1
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following tables provides information by level for the Company’s assets that were measured at fair value on a recurring basis (in thousands):
March 31, 2026
Level 1Level 2Total
Assets
Cash and cash equivalents:
Money market funds$60,427 $— $60,427 
Short-term investments:
Commercial paper— 30,420 30,420 
Corporate debt securities— 63,978 63,978 
Total short-term investments— 94,398 94,398 
Total financial assets$60,427 $94,398 $154,825 
December 31, 2025
Level 1Level 2Total
Assets
Cash and cash equivalents:
Money market funds$54,475 $— $54,475 
Short-term investments:
Commercial paper— 68,326 68,326 
Corporate debt securities— 72,846 72,846 
Total short-term investments— 141,172 141,172 
Total financial assets$54,475 $141,172 $195,647 
Schedule of Outstanding Derivative Instruments
The following table summarizes the Company’s outstanding derivative instruments on a gross basis as recorded in its condensed consolidated balance sheets as of March 31, 2026 (in thousands):
At March 31, 2026
 Notional AmountBalance Sheet Line ItemDerivative Liabilities Fair Value
Undesignated hedges: Forward foreign currency exchange contracts
$4,500 (a)$99 
(a) Other current liabilities